Page under maintenance | mavacamten▼ UK

Skip to main content

Obstructive
HCM

About obstructive HCM

Identifying patients

Treatment landscape

Patient profiles

Symptoms and Diagnosis

Echocardiography and obstructive hypertrophic cardiomyopathy

About
Mavacamten

NICE recommendations

Clinical
Studies

EXPLORER-HCM primary endpoint

EXPLORER-HCM secondary endpoints

EXPLORER-HCM exploratory endpoints

VALOR-HCM primary endpoint

EXPLORER-LTE durable efficacy

Important information

Drug interactions

Dosing and initiation

Maintenance and interruption

Special populations

This section of the website is currently undergoing maintenance

We are working to resolve this as soon as possible. Please check back shortly.

horizontal Rule

References

Legal Notice | Privacy Policy

© 2026 Bristol-Myers Squibb Company.

3500-GB-2500047 | March 2026